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Background: Nitric oxide (NO) is a multifunctional signaling molecule that regulates important cellular events in
inflammation including leukocyte recruitment. Previous studies have shown that pharmacological inhibition of NO
synthesis induces leukocyte recruitment in various in vitro and animal models. However, it is not known whether
NO modulation has similar effects on leukocyte-endothelial cell interactions within the human microvasculature.
The present study explored the effect of systemic L-NAME treatment on leukocyte recruitment in the SCID-hu
mouse model.
Methods: Human skin xenografts were transplanted in SCID mice to study human leukocyte dynamics in human
vasculature. Early events of human leukocyte recruitment in human vasculature were studied using intravital
microscopy. NO synthesis was pharmacologically inhibited using NG-nitro-L-arginine methyl ester (L-NAME).
Immunohistochemical analysis was performed to elucidate E-selectin expression in human xenograft skin. Human
neutrophil-endothelial cell interactions were also studied in an in vitro flow chamber assay system. P- and E-selectin
expression on cultured human umbilical vein endothelial cells (HUVECs) was measured using ELISA. Platelet-
activating factor (PAF) synthesis was detected using a TLC-based assay.
Results: L-NAME treatment significantly enhanced the rolling and adhesion of human leukocytes to the human
vasculature. Functional blocking of P- and E-selectins significantly inhibited rolling but not adhesion induced by
inhibition of NO synthesis. Systemic L-NAME treatment enhanced E-selectin expression in human xenograft skin.
L-NAME treatment significantly enhanced P- and E-selectin expression on HUVECs. L-NAME treatment did not
significantly modify neutrophil rolling or adhesion to HUVECs indicating that L-NAME−induced subtle P- and
E-selectin expression was insufficient to elicit dynamic neutrophil-HUVEC interactions in vitro. Moreover, synthesis of
endothelial-derived PAF was not significantly modified by L-NAME treatment. These results point to the accelerated
leukocyte recruitment in human vasculature following suppression of NO synthesis, effects that are mediated by
P- and E-selectins. The findings are, however, not supported by the in vitro data.
Conclusion: Inhibition of endogenous NO triggers early events of human leukocyte recruitment in human
vasculature, involving complex cellular or molecular mechanisms in addition to P- and E-selectin-mediated
leukocyte rolling.
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Leukocyte recruitment is a dynamic cellular and molecu-
lar process in inflammation and constitutes leukocyte
tethering, rolling, adhesion and ultimately emigration
from the microvasculature [1-3]. The pleiotropic functions
of the endogenous mediator nitric oxide (NO) include
suppressing inflammatory responses such as leukocyte re-
cruitment [4,5]. The mechanisms of leukocyte adhesion
and emigration elicited by NO suppression are not com-
pletely understood [6]. The induction of NO through in-
ducible NO synthase was previously shown to attenuate
neutrophil chemotaxis [7-11]. NG-nitro-L-arginine methyl
ester (L-NAME) inhibits the biosynthesis of NO from L-
arginine by NO synthase. L-NAME pre-treatment was
previously shown to increase leukocyte adhesion [12-14]
and inhibit transendothelial migration of neutrophils
[15]. Modulation of endogenous NO synthesis may fur-
ther participate in F-actin depolymerization and expres-
sion of integrins [16].
NO has been shown to modulate the expression of
selectins [17] which mediate tethering and rolling dur-
ing leukocyte recruitment. L-NAME treatment may en-
hance the expression of endothelial adhesion molecules
[13] such as P-selectin expression and enhance
leukocyte rolling and adhesion [18]. NO inhibition may
also stimulate degranulation of mast cells which release
pro-inflammatory mediators that upregulate P-selectin
expression [19,20]. Previous studies demonstrated that
oxidant-induced P-selectin expression and leukocyte
rolling were enhanced by the inhibition of endogenous
NO [21]. However, the mechanism by which NO stimu-
lates rapid mobilization of P-selectin fostering early
leukocyte recruitment in vivo remains elusive.
The firm adhesion of leukocytes is mediated by
platelet-activating factor (PAF) synthesis but it is unclear
whether endogenous NO regulates the synthesis of this
phospholipid. The role of NO in the modulation of E-
selectin expression and function is not completely
understood. In unstimulated endothelial cells, inhibition
of NO synthesis for up to 4 h has no effect on E-selectin
expression [22]. In IL-1α-stimulated endothelial cells,
NO decreased E-selectin expression whereas other
investigators did not observe the effects of NO on
cytokine-induced E-selectin expression [6,23]. As ex-
pression and function are not always synonymous and
since the functional assessment of selectins requires flow
conditions, the potential effects of endogenous NO on
the functions of P-selectin and E-selectin during
leukocyte recruitment in human microvasculature re-
quire additional investigation.
Discrepancies exist in the exact role of NO in leukocyte
recruitment due to the diversity of pharmacological
approaches, tissues, and animal models studied. The
present study explored the effect of NO modulation by L-NAME treatment on human leukocyte recruitment in
human vasculature in the SCID-Hu mouse model and on
the expression and function of selectins and PAF in vitro.
Methods
SCID-hu mouse model
CB-17 SCID mice (Harlan, Mississauga, ON), 6–8 weeks
of age were grafted with partial thickness human skin
according to a previously described protocol [24,25].
Animal protocols were approved by the local Animal
Care Committee and met the guidelines of the Canadian
Council for Animal Care. Briefly, partial thickness skin
grafts from healthy human donors were prepared from
discarded skin obtained from breast reduction surgeries
using a 0.1-in. dermatome. A portion of the posterior
thorax on the back (5 mm × 5 mm) was excised in halo-
thane anesthetized recipient mice and human skin of the
same size was placed and allowed to heal for 4 weeks be-
fore the mice were used for intravital microscopy. In the
SCID-hu mouse model, transplanted human skin retains
human dermal microvascular bed which connects with
the mouse microvasculature as a result of spontaneous
anastomosis [25].
Isolation and labelling of human leukocytes
Twenty mL of heparinised blood collected from healthy
volunteers was centrifuged (1350 rpm, 7 min, room
temperature) and the buffy coat was collected and
washed with HBSS containing Ca2+ and Mg2+ (Gibco,
Grand Isle, NY). To study the interactions between
human leukocytes and human vascular endothelium of
human skin graft in SCID mice using fluorescent intravi-
tal microscopy, human leukocytes were labelled with
rhodamine 6-G (0.025 % final concentration, 5 min;
Sigma, St. Louis, MO). Unbound rhodamine 6-G was
removed by washing three times in HBSS.
Intravital microscopy
Mice were administered with L-NAME (50 mg/kg b.w., i.
p.; Bachem, Torrance, CA) for 4 h before viewing the
human skin microvasculature using intravital micros-
copy. Animals were anesthetised i.p. with ketamine
(160 mg/kg b.w.) and xylazine (10 mg/kg b.w.) and body
temperature was regulated using a heating pad [24].
Functional blocking antibodies and additional anesthetic
was introduced through a cannulated jugular vein and
infusion of rhodamine 6-G-labelled human leukocytes
was through cannulated carotid artery. A flap consisting
of the human skin graft was laid flat onto a pedestal,
secured with suture, perfused with 37 °C-warmed saline
and covered with a glass coverslip. The preparation was
examined using an upright fluorescent microscope (Opti-
phot-2; Nikon) with a 20× water immersion objective. To
identify human vessels, 100 mg of FITC-labelled Ulex
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fluorescence microscopic visualization (excitation: 450–
490 nm and emission: 520 nm). Rhodamine 6-G-labelled
human leukocytes were visualized by excitation at 510–
560 nm using a 590 nm emission filter. Images of the la-
belled human leukocytes and human microvessels were
visualized using a silicon-intensified CCD camera (C-
2400-08; Hamamatsu Photonics, Bridgewater, NJ) and
recorded for playback analysis. Rolling of human leuko-
cytes was expressed as percentage flux fraction, deter-
mined by counting the number of interacting human
leukocytes in an individual vessel relative to the total
number of human leukocytes passing through the vessel
over the same period (determined by frame-by-frame
analysis). Rhodamine 6-G-labelled human leukocytes that
remained stationary on the vascular wall for at least 30 s
were defined as adherent. Recording was started immedi-
ately after infusion of the labelled-leukocytes and the
interactions were recorded for 30 min, a time point when
the number of circulating labelled leukocytes was signifi-
cantly diminished. Where indicated, the blocking mAbs
(20–40 μg/mL) anti-human P-selectin G1 (BD Bios-
ciences, Mississauga, ON) and/or anti-human E-selectin
ES1 (kindly provided by Dr. KD Patel, University of Cal-
gary, Calgary, AB), were injected i.v. as a bolus in a total
volume of 100 μL of PBS after baseline interactions had
been recorded. The antibodies were allowed to circulate
for 2–3 min before a second bolus of human leukocytes
was injected. Functional blocking is expected not to re-
verse leukocyte adhesion. Analysis of selectin functional
blocking was thus, performed by determining the num-
ber of adherent leukocytes 5 min after the administration
of blocking mAb.
Immunohistochemical analysis
Human skin samples were harvested from representative
SCID mice after intravital microscopy. These samples were
then frozen in OCT and cut into 5-μm thick sections.
Sections were stained with polyclonal goat anti-human E-
selectin antibody to examine the level of E-selectin expres-
sion and then with biotin-conjugated secondary rabbit anti-
goat antibody (Jackson ImmunoResearch Laboratories,
Burlington, ON). Color was developed using the ABC kit
(Vector Laboratories, Burlingam, CA) and chromagen
diaminobenzadine (Sigma) and the sections were then
counterstained with Gill II hematoxylin. Images were cap-
tured using a CCD digital camera (Nikon).
Cell culture
Human umbilical vein endothelial cells (HUVECs) were
harvested from fresh human umbilical cords and cultured
as described previously [26]. After confluence was reached,
the cultured HUVECs were trypsinzied for detachment
and then seeded onto fibronectin-coated coverslips or 48-well plates. Since senescent endothelial cells express 50 %
to 75 % less eNOS mRNA compared to their primary or
first-passaged counterparts [27], HUVECs were, thus, used
at first passage for all experiments.
Isolation of human neutrophils
Human neutrophils were isolated from ACD (Acid Citrate
Dextrose) anti-coagulated whole blood from healthy
donors. After dextran (Spectrum Chemicals, Gardena, CA)
sedimentation, isolation of neutrophils was performed at
room temperature by using centrifugation through a dens-
ity gradient of Ficoll Type 400 (Sigma) with 10 % Hypaque
SodiumW (Sterling-Winthrop, Markham, ON). Isolated
neutrophils were 97 % pure and 95 % viable. Purified
human neutrophils were resuspended in HBSS with Ca2+
and Mg2+ at a concentration of 1×106 cells/mL prior to
use in laminar flow chamber assay.
Laminar flow chamber assay
Coverslips with cultured HUVECs were mounted in a par-
allel plate flow chamber [28]. Reagents were added to the
neutrophil suspension at the indicated time. The flow
chamber was placed onto the stage of an inverted micro-
scope (Carl Zeiss, Toronto, ON) and HUVEC monolayers
were visualized at 100× magnification using phase con-
trast imagery with a 0.45 mm2 field of view. The stage area
was enclosed in a warm air cabinet and maintained at 37°
C prior to perfusion using a water bath. A syringe pump
(Harvard Apparatus, Laval, QC) was used to draw the
cells through the flow chamber at 2 dynes/cm2 for 20 min.
Experiments were recorded via a CCD camera for analysis.
Interacting cells were either rolling or adherent to the
surface of the cover slip. A neutrophil that remained sta-
tionary for 10 sec or more was considered as adherent.
Measurement of endothelial cell surface expression of
P- and E-selectins
Surface P- and E-selectin expression on HUVECs was
measured by ELISA. Cells were plated into a 48-well
plate and used 24−48 h later. HUVEC monolayers were
exposed to L-NAME or histamine (Sigma) for 10 min to
induce P-selectin upregulation and with L-NAME or re-
combinant human TNFα (Collaborative Biochemical
Products; Bedford, MA) for 4 h for E-selectin upregula-
tion. After fixation (1 % formalin at 4 °C for 30 min) and
rinsing with PBS, blocking was performed with 1 % BSA
in PBS (30 min at 37 °C). The cells were incubated with
the anti-P-selectin antibody S12 (2 μg/mL) or with the
anti-E-selectin antibody EL246 (50 μg/mL) for 30 min at
37 °C, washed with 0.05 % Tween-20 followed by incuba-
tion (30 min at 37 °C) with the secondary antibody (per-
oxidase labelled goat-anti-mouse, 1:1000 dilution).
Absorbance was measured at 450 nm after addition of
TMB substrate (Dako Carpinteria, CA) and 0.01 H2SO4.
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To determine the effect of L-NAME on PAF synthesis, a
previously described method was used [29]. Briefly,
HUVECs were incubated with L-NAME (100 μM) for
10 min at 37 °C in the presence of 3H-acetate. Histamine
(10-5 or 10-6 M) or HBSS was then added to HUVECs
and further incubated for 5 min at 37°C. The cells were
then incubated with acidified methanol, scraped and
added to a Bligh-Dyer extraction with cold PAF. Metha-
nol was added until a monophase which was then split.
After centrifugation (800–1000 rpm), the upper phase
was removed and the lower phase was dried and spotted
on a TLC plate and the resultant spots counted.
Statistical analysis
Data are expressed as means ± SEM. As indicated in the
figure legends, the statistical analysis in two value sets
was made using paired or unpaired Student’s t test and
the statistical differences among the multiple groups
were analyzed by ANOVA and post hoc comparisons by
the Tukey-Kramer Multiple Comparison Test. Values of
p< 0.05 were considered statistically significant.
Results
In the first series of experiments, we analyzed the
in vivo effects of systemic L-NAME treatment (50 mg/
kg b.w.) on human leukocyte recruitment in the human
vasculature. Rhodamine 6-G-labelled human leukocytes
were infused into SCID mice bearing human skin trans-
plant and the interaction between the labelled human
leukocytes and FITC-Ulex europaeus labelled-human
microvasculature was visualized using fluorescence
intravital microscopy (Figure 1).
Systemic L-NAME treatment significantly enhanced
the rolling and adhesion of labeled leukocytes to the
human vasculature. The involvement of P- and E-
selectins in this process was determined utilizing two
blocking antibodies directed against surface-expressed
P- and E-selectins. As shown in Figure 2A, in the ab-
sence of L-NAME treatment (control), the rolling fluxFigure 1 Human leukocyte interactions with the human microvasculatur
human post-capillary venule from the control SCID-hu mouse. B. Represent
adhering to a Ulex europaeus-stained human post-capillary venule after 4-hofraction was virtually undetectable as the number of la-
beled human leukocytes constitutes a relatively low pro-
portion of the total circulating leukocytes despite
baseline E-selectin expression (n = 4; number of vessels =
7). L-NAME treatment significantly enhanced the roll-
ing flux fraction and blocking either P-selectin (n = 3;
number of vessels = 9) or E-selectin (n = 2; number of
vessels = 4) tended to decrease this process. Blocking
both P- and E-selectins, however, significantly blunted
the increased rolling flux fraction induced by L-NAME
treatment (P< 0.05). Furthermore, L-NAME treatment
significantly increased the number of adherent human
leukocytes to the human vascular endothelium
(Figure 2B). Blocking of either P- or E-selectin or both,
however, did not modify leukocyte adhesion pointing to
P- and E- selectin independent mediation of L-NAME-
triggered leukocyte adhesion.
Immunohistochemical analysis revealed the increased
E-selectin expression in human skin vessels from L-
NAME-treated mice in comparison to the human skin
in untreated mice (Figure 3) pointing to the regulation
of E-selectin expression in human microvasculature by
endogenous NO.
In view of these observations, together with the lim-
itations of complexity and nonspecificity of cellular
reactions in vivo, we tested the hypothesis that NO de-
pletion affects P- and E-selectin expression and func-
tion in human endothelial cells in vitro. HUVECs
treated with L-NAME (100 μM) for 10 min showed a
significant increase in the expression of P-selectin in
comparison to untreated HUVECs. Histamine treat-
ment (25 μM) also produced a significant increase in
P-selectin expression (Figure 4A). Additional experi-
ments explored the effects of increased P-selectin ex-
pression on HUVECs on neutrophil rolling or
adhesion in an in vitro flow chamber. L-NAME treat-
ment had no effect on the rolling or adhesion of neu-
trophils over the time points studied, whereas
histamine treatment significantly increased neutrophil
rolling and adhesion (Figures 4B and 4C).e. A. Representative image of a FITC-conjugated Ulex europaeus-stained
ative image of rhodamine 6-G labelled human leukocytes rolling and
ur L-NAME treatment (50 mg/kg b.w., i.p.) in SCID-hu mice.
Figure 2 L-NAME-elicited human leukocyte rolling and adhesion in vivo. A. Leukocyte rolling flux fraction in untreated mice (control, white
bar) and L-NAME (50 mg/kg b.w., i.p.)-treated mice (black bars). ** indicates P< 0.01 difference from untreated mice (t test). # indicates P< 0.05
difference from L-NAME-treated group in the absence of functional blocking antibodies (t test). + and – indicate the presence and absence of
functional blocking anti-P- and/or anti-E-selectin antibodies, respectively. Data are means ± SEM (n= 2−6; number of vessels studied= 4−13;
control: n = 4; number of vessels = 7). B. Leukocyte adhesion in untreated mice (control, white bar) or L-NAME (50 mg/kg b.w., i.p.)-treated mice
(black bars). * and ** indicate P< 0.05 and P< 0.01 respectively from untreated mice (t test). + and – indicate the presence and absence of
functional blocking anti-P- and/or anti-E-selectin antibodies, respectively. Data are means ± SEM (n= 3−8; number of vessels studied= 4−16;
control: n = 4; number of vessels = 8).
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NO synthesis inhibition on E-selectin expression and
function. HUVECs treated with L-NAME (100 μM) or
TNFα (10 ng/ml) for 4 h showed a significant increase
in E-selectin expression in comparison to untreated
HUVECs (Figure 5A). Following TNFα treatment, there
was a significant increase in neutrophil rolling and adhe-
sion, while L-NAME treatment had no effect (Figures 5B
and 5C) pointing to a discrepancy between P- and E-
selectin expression and function in vitro.
As PAF may foster adherence of leukocytes on endothe-
lium, additional experiments were performed to investigate
the effect of inhibiting endothelial NO on PAF synthesis.
Treatment of HUVECs with 100 μM L-NAME did not sig-
nificantly modify PAF synthesis (229.3 ± 64.0 cpm, n=3) in
comparison to untreated HUVECs (186.6 ± 2.6 cpm, n=3).Figure 3 L-NAME-induced upregulation of E-selectin expression in viv
showing E-selectin expression (arrow) in human microvasculature of the hu
panel) and 4 h following L-NAME administration (50 mg/kg b.w., i.p., rightAddition of 10 μM histamine to HUVECs significantly
augmented PAF synthesis. However, there was no signifi-
cant difference in histamine-induced PAF synthesis be-
tween HUVECs treated with 100 μM L-NAME
(3797.3 ± 1157.3 cpm, n=3) and untreated HUVECs
(3360.0 ± 746.6 cpm, n= 3). These results suggest endothe-
lial mechanisms independent of PAF synthesis in L-
NAME-modulated early events of rolling and adhesion in
leukocyte recruitment.
Discussion
The present study discloses a novel approach to investi-
gate the mechanism of leukocyte recruitment in human
vasculature, a model of using intravital microscopy to
directly visualize and determine human leukocyte-
endothelial cell interactions in vivo. This method waso. Immunohistochemical analysis (representative of 4 specimens each)
man skin xenografts in SCID-hu mice without treatment (control, left
panel).
Figure 4 L-NAME-sensitive P-selectin expression and function
in vitro. A. Endothelial P-selectin expression in controls (white bar)
and after treatment with L-NAME (100 μM) or histamine (25 μM) for
10 min (black bars). * and ** indicate P< 0.05 and P< 0.01,
respectively, difference from the control (t test). Data are
means ± SEM (n= 4). B. Rolling neutrophils before and after
treatment of HUVECs with 100 μM L-NAME (white squares) or 25 μM
histamine (black squares). * indicates P< 0.05 difference from the
value prior to treatment (ANOVA). Data are means ± SEM (n = 4).
C. Adherent neutrophils before and after treatment of HUVECs with
100 μM L-NAME (white squares) or 25 μM histamine (black squares).
* indicates P< 0.05 difference from the value prior to treatment
(ANOVA). Data are means ± SEM (n = 4).
Figure 5 L-NAME-sensitive E-selectin expression and function
in vitro. A. Endothelial E-selectin expression in controls (white bar)
and 4 hours after treatment with L-NAME (100 μM) or TNFα (10 ng/
mL) (black bars). * and ** indicate P< 0.05 and P< 0.01, respectively,
difference from the control (t test). Data are means ± SEM (n= 4). B.
Rolling neutrophils 4 h after treatment of HUVECs with 100 μM L-
NAME (white squares) or 10 ng/ml TNFα (black squares). * indicates
P< 0.05 difference from the value at time point 0 min (ANOVA).
Data are means ± SEM (n = 4). C. Adhesion of neutrophils 4 h after
treatment of HUVECs with 100 μM L-NAME (white squares) or
10 ng/mL TNFα (black squares). * indicates P< 0.05 difference from
the value at time point 0 min (ANOVA). Data are means ± SEM
(n = 4).
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study of the interactions between Plasmodium falciparum-
infected human erythrocytes and human endothelium [24].
Studies performed in various in vitro or animal models
have shown the role of NO-mediated signaling in leukocyte
recruitment [12,14,30-34], but studies on human vascula-
ture have not been reported. Using intravital microscopy,
we investigated early recruitment steps of human leukocyte
rolling and adhesion in human microvasculature in the
SCID-hu mouse model. We show that inhibition of NO
synthesis with L-NAME enhances early human leukocyte
recruitment steps of rolling and adhesion in vivo. Our
results of enhanced rolling and adhesion of human leuko-
cytes on human vessels after inhibiting NO synthesis are
consistent with previous studies [14,30,35].
As shown previously, selectins mediate leukocyte rolling
but not adhesion [36-41]. In this study we demonstrate that
in microvasculature of human skin, functional blocking of
P- and E-selectins resulted in a decrease of rolling but not
adhesion elicited by L-NAME. The interplay between en-
dogenous NO and endothelial selectin expression remains
unclear although previous studies show that inhibition of
NO may enhance the expression of endothelial adhesion
molecules including selectins [42,43]. E-selectin expression
was previously shown to be modulated by L-NAME [44]
an effect that may be mediated by NF-κB [45]. The present
study further reveals that L-NAME treatment in vitro
increased the expression of both P- and E-selectins which,
however, did not effect either rolling or adhesion under
in vitro flow conditions. We observed subtle but signifi-
cantly enhanced endothelial P-selectin expression following
10 min of L-NAME treatment. In contrast, prolonged L-
NAME treatment was previously shown to trigger P-
selectin synthesis rather than its rapid mobilization in
endothelial cells as evidenced by increased P-selectin
mRNA levels [46,47]. It has previously been reported that
L-NAME treatment upregulated P-selectin expression and
stimulated neutrophil rolling and adhesion in vitro [21].
However, these observations were made at relatively lower
shear rates and on bovine arterial endothelium in contrast
to HUVECs used in the present study. Interestingly, NO
generation in cultured endothelial [48] and smooth muscle
cells [49] may be sensitive to in vitro flow conditions.
The discrepancy between our in vitro and in vivo
observations may be attributed to the complexity of cel-
lular interactions and associated mediators in vivo. It is
intriguing to speculate the role of mast cells in NO-
mediated leukocyte recruitment in vivo as they are in a
close proximity to the vasculature and display enhanced
sensitivity to pro-inflammatory mediators. Mast cell sta-
bilizers were reported to attenuate L-NAME-induced
leukocyte recruitment in vivo [50]. Addition of L-NAME
to a co-culture of mast cells and endothelial cells was in-
deed shown to stimulate leukocyte adhesion [51] whichmay be mediated by the generation of peroxynitrite [52].
Furthermore, mast cell degranulation was shown to
upregulate E-selectin expression and leukocyte recruit-
ment in the SCID-hu mouse model [35]. We observed
that endothelial PAF synthesis upon stimulation with L-
NAME in vitro was not significantly modified which pro-
vides further evidence to the involvement of other
players, such as mast cells, during leukocyte recruitment.
Conclusions
The present observations reveal that pharmacological in-
hibition of NO synthesis by L-NAME enhances human
leukocyte rolling and adhesion in the human microvas-
culature. L-NAME triggered rolling is mediated by
P- and E-selectin expression. Although the increased ex-
pression of selectins on isolated HUVECs did not modify
the functions of rolling and adhesion in vitro, it strongly
suggests the implication of other possible players in L-
NAME-mediated human leukocyte recruitment in vivo.
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